GlaxoSmithKline S.A.E (EGX:BIOC)
38.13
+0.06 (0.16%)
At close: Jun 25, 2025
GlaxoSmithKline S.A.E Market Cap
GlaxoSmithKline S.A.E has a market cap or net worth of 3.18 billion as of June 27, 2025. Its market cap has increased by 31.57% in one year.
Market Cap
3.18B
Enterprise Value
3.04B
Revenue
3.27B
Ranking
n/a
PE Ratio
13.15
Stock Price
38.13
Market Cap Chart
Since August 23, 2005, GlaxoSmithKline S.A.E's market cap has increased from 569.45M to 3.18B, an increase of 459.20%. That is a compound annual growth rate of 9.06%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Commercial International Bank Egypt (CIB) S.A.E. | 255.32B |
El Sewedy Electric Company | 159.49B |
Talaat Moustafa Group Holding | 114.79B |
Eastern Company S.A.E | 91.50B |
Misr Fertilizer Production Company | 70.71B |
Alexandria Container&Cargo Handling Company | 66.80B |
Egypt Aluminum | 64.73B |
Telecom Egypt Company | 61.52B |